Isolation of Photosystem I Reaction Center Preparation From Spinach
Time of Update: 2021-03-10
This chapter deals with the preparation of photochemically active reaction center particles (Type III) that basically contain only two subunits, PsaA and PsaB. The preparation is obtained by further treating the Type II preparation
Biochemical Dissection of RNA Silencing in Plants
Time of Update: 2020-12-27
These comprehensive protocols should prove useful in the further dissection of the plant RNA silencing pathway,as well as for the validation of the predicted targets of endogenous plant microRNAs.
Meningococcal vaccine Men Quardfi has been approved by the European Union
Time of Update: 2020-12-11
the Sanofi vaccine with all other vaccines on the market, proving that MenQuadfi is safe and producing a high immune response to all four serotypes throughout the study.
J affect dis: new development of Mycobacterium tuberculosis research
Time of Update: 2020-02-15
February 13, 2020 / Biovalley BIOON / -- in September 2018, the National Institute of allergy and infectious diseases (NIAID) of the National Institutes of Health (NIH) released
Another original new drug of Hengrui has entered the clinic, and netizens are optimistic about
Time of Update: 2019-11-22
" Forbes magazine also pointed out that 95% of new drugs developed by US pharmaceutical companies failed to go on the market.
New progress has been made in the construction of spiro skeleton by C-H bond activation in Dai Huixiong group, Shanghai Institute of medicine, Chinese Academy of Sciences
Time of Update: 2019-07-19
Dai Huixiong group of Shanghai Institute of medicine, Chinese Academy of Sciences has long been committed to the exploration of new C-H bond activation reaction and its application in new drug research and development.
"Rhodium" and "sulfur" - ligand promoted Rh (III) - catalyzed C-H bond sulfurization
Time of Update: 2019-05-22
Recently, Professor Sun Weiyin, associate professor of Luyi, School of chemistry and chemical engineering, Nanjing University, and Professor Yu Jinquan of Scripps Research
Theme Salon of "thinking about the transformation of imitated pharmaceutical enterprises and the selection of product project approval
Time of Update: 2019-04-26
Yaozhi.com sincerely welcomes the pharmaceutical elites in the industry to participate in this activity and gather together to discuss the transformation of generic pharmaceutical enterprises and the selection of project project approval.
Research team of Professor Guan Wei and Professor Su Zhongmin, Northeast Normal University
Time of Update: 2018-07-30
Because of the synergistic effect between two different catalysts, the double catalysis has become an ideal choice
However, little is known about its synergistic
The world's first type 1A treatment drug for Charcot muscular atrophy was approved in domestic clinical trials
Time of Update: 2018-06-15
Source: Sina pharmaceutical June 14, 2018, Tishi pharmaceutical According to the announcement of the Group Co., Ltd., its holding subsidiary, Tianshili international gene network
China's first indigenous original anti hepatitis C innovative drug approved for market
Time of Update: 2018-06-13
Source: Geli, June 13, 2018, announced today that the first innovative anti hepatitis C drug developed by the company, gonovir ® (asco08), has been approved for listing
Weigh! China's first indigenous original anti hepatitis C innovative drug approved for market
Time of Update: 2018-06-13
GOLLY today announced that the first innovative anti hepatitis C drug developed by the company, gonovir ® (asco8), has been approved for marketing by the State Drug Administration
[unlisted company roadshow] brings many high-quality projects to the investment community
Time of Update: 2017-11-05
Source: China pharmaceutical innovation promotion association held 5 road shows of unlisted companies at the "Second China Pharmaceutical Innovation and investment conference
Progress of major new drug development projects in China in 2016
Time of Update: 2017-03-03
It can directly carry out phase III clinical trials in the United States to treat wet age-related macular degeneration, marking that conbercept has been affirmed in quality standards, drug efficacy and safety in the process of entering the international market.
Where do we need to improve the development trend of global pharmaceutical industry
Time of Update: 2016-11-04
Table 3: research spending per new drug (1997-2011) table 3: data from ppt of covence pharmaceuticals 9 conference cost elements of new drug control Procedures, administrative staff, site monitoring costs.
Letter on Soliciting Opinions on procedures for registration of relevant medical devices
Time of Update: 2015-09-29
Procedures for change and filing of medical device instructions Department of mechanical registration, food and Drug Administration 2015-09-28 (Disclosure attribute: active disclosure) sfjxxgxb  No. 61, Appendix 1.
Notice of the State Food and Drug Administration on the clinical trials conducted by drug clinical trial institutions and contract research organizations (No. 172, 2015
Time of Update: 2015-09-11
Source: CFDA 2015-9-11 on August 25, 2015, the State Food and Drug Administration issued the notice on self inspection of clinical trial data of drugs (No
169 in 2015
Sun Hongbin's team of China Pharmaceutical University approved the clinical trial of class 1.1 new antithrombotic drug "Viagra tablet
Time of Update: 2015-04-21
Sun Hongbin, a distinguished professor of "Yangtze River Scholar" from the Institute of Pharmaceutical Sciences, China Pharmaceutical University, and Jiangsu Weikeli pharmaceutical
Lilly and Hehuang Sinopharm carry out R & D and operation cooperation of tumor drugs in China
Time of Update: 2013-10-10
"We believe that furoquinone is potentially active in many high incidence rate tumors, and may benefit patients who are significantly unsatisfied with China's medical needs," he added.
The main goal of the late research of Novartis acromegaly
Time of Update: 2012-05-07
HERV é hoppenot, President of cancer Department of Novartis, said: "the positive results of phase III study show that pasireotide lar has therapeutic effect on acromegaly patients with treatment demand.